CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use.

This proof-of-concept study is sponsored by SynerFuse, Inc., and is conducted under an approved IDE (G1900454) from FDA. Safety and efficacy for this indication have not been established.

Feasibility Study Completed
15 fusion patients

Sites: Minneapolis, Minnesota and South Bend, Indiana. 

SynerFuse® has partnered with RQM+ for clinical trial monitoring and regulatory services.